Results for tag: "Phenylketonuria Drug"

Phenylketonuria (PKU) is a rare genetic disorder that affects the metabolism of the amino acid phenylalanine. It is treated with a special diet and medication. Endocrine and Metabolic Disorders Drugs are used to treat a variety of conditions, including PKU. These drugs are designed to help the body regulate hormones, enzymes, and other substances that are essential for normal functioning. The Phenylketonuria Drug market is composed of a variety of products, including enzyme replacement therapy, dietary supplements, and drugs that reduce phenylalanine levels. These drugs are used to treat the symptoms of PKU and to prevent further complications. The market is highly competitive, with many companies offering different products. Some of the companies in the Phenylketonuria Drug market include Biomarin Pharmaceuticals, Amicus Therapeutics, and BioMarin Pharmaceuticals International. Other companies include Genzyme Corporation, Shire Pharmaceuticals, and Sanofi-Aventis. These companies are dedicated to providing innovative treatments for PKU and other endocrine and metabolic disorders. Show Less Read more